Ben Fredj, Manel
Garrach, Behaeddin
Bennasrallah, Cyrine
Migaou, Asma
Abroug, Hela
Dhouib, Wafa
Zemni, Imen
Kacem, Meriem
Bouanene, Ines
Belguith Sriha, Asma
Article History
Received: 28 December 2021
Accepted: 2 June 2022
First Online: 10 June 2022
Declarations
:
: The study protocol was reviewed and approved by the institutional ethics committee of the University of Sousse on June 2016. The researchers ensure that the study was conducted in compliance with principles of the Declaration of Helsinki. Clinical trial registration was made in the Pan African Clinical Trial Register (ExternalRef removed) database (PACTR202110595729653), 06/10/ 2021. An oral consent was taken from all participants. It was considered that the oral form may be sufficient because of two reasons: the research presents a minimal risk for participants, and because that the procedure of written consent’s obtention may lead to unnecessary distress and decrease the inclusion rate among participants.This written consent waiver was approved by the ethics committee.
: Not applicable
: No conflict of interest was declared by the authors.